These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 36324078)
61. Childhood chronic inflammatory demyelinating polyneuroradiculopathy--three cases and a review of the literature. Riekhoff AG; Jadoul C; Mercelis R; Cras P; Ceulemans BP Eur J Paediatr Neurol; 2012 Jul; 16(4):315-31. PubMed ID: 22225859 [TBL] [Abstract][Full Text] [Related]
62. Chronic inflammatory demyelinating polyradiculoneuropathy relapse after mexiletine withdrawal in a patient with concomitant myotonia congenita: A case report on a potential treatment option. Portaro S; Biasini F; Bramanti P; Naro A; Calabrò RS Medicine (Baltimore); 2020 Jul; 99(28):e21117. PubMed ID: 32664137 [TBL] [Abstract][Full Text] [Related]
63. A subset of fibromyalgia patients have findings suggestive of chronic inflammatory demyelinating polyneuropathy and appear to respond to IVIg. Caro XJ; Winter EF; Dumas AJ Rheumatology (Oxford); 2008 Feb; 47(2):208-11. PubMed ID: 18208823 [TBL] [Abstract][Full Text] [Related]
64. Utility of somatosensory evoked potentials in the assessment of response to IVIG in a long-lasting case of chronic immune sensory polyradiculopathy. Clerici AM; Nobile-Orazio E; Mauri M; Squellati FS; Bono GG BMC Neurol; 2017 Jul; 17(1):127. PubMed ID: 28668085 [TBL] [Abstract][Full Text] [Related]
65. Resolution of chronic inflammatory demyelinating polyneuropathy-associated central nervous system lesions after treatment with intravenous immunoglobulin. Fee DB; Fleming JO J Peripher Nerv Syst; 2003 Sep; 8(3):155-8. PubMed ID: 12904236 [TBL] [Abstract][Full Text] [Related]
66. Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy: the ICE trial. Hughes RA Expert Rev Neurother; 2009 Jun; 9(6):789-95. PubMed ID: 19496683 [TBL] [Abstract][Full Text] [Related]
69. [A women with aplastic anemia developed chronic inflammatory demyelinating polyneuropathy]. Abe M; Shimizu F; Suzukawa M; Maeda T; Omoto M; Kanda T Rinsho Shinkeigaku; 2019 Dec; 59(12):818-822. PubMed ID: 31761833 [TBL] [Abstract][Full Text] [Related]
71. Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyradiculoneuropathy, a time to start and a time to stop. Adrichem ME; Eftimov F; van Schaik IN J Peripher Nerv Syst; 2016 Sep; 21(3):121-7. PubMed ID: 27241239 [TBL] [Abstract][Full Text] [Related]
77. Chronic Inflammatory Demyelinating Polyneuropathy Variant with Creatine-Kinase Elevation and Vanishing Effect of Immunoglobulins. Finsterer J; Aliyev R Am J Case Rep; 2017 Jul; 18():834-838. PubMed ID: 28747620 [TBL] [Abstract][Full Text] [Related]
78. IgPro20, the Polyneuropathy and Treatment with Hizentra Berger M; Harbo T; Cornblath DR; Mielke O Immunotherapy; 2018 Aug; 10(11):919-933. PubMed ID: 29764262 [TBL] [Abstract][Full Text] [Related]
79. Combined intravenous immunoglobulin and methylprednisolone as induction treatment in chronic inflammatory demyelinating polyneuropathy (OPTIC protocol): a prospective pilot study. Adrichem ME; Bus SR; Wieske L; Mohammed H; Verhamme C; Hadden R; van Schaik IN; Eftimov F Eur J Neurol; 2020 Mar; 27(3):506-513. PubMed ID: 31571349 [TBL] [Abstract][Full Text] [Related]
80. Chronic inflammatory demyelinating polyneuropathy: considerations for diagnosis, management, and population health. Ryan M; Ryan SJ Am J Manag Care; 2018 Sep; 24(17 Suppl):S371-S379. PubMed ID: 30312032 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]